Mark Nolan
-
- Chemotherapy-induced cardiotoxicity and mitigation 14
- Cardiovascular Function and Risk Factors 9
- Cardiac Valve Diseases and Treatments 2
- Cardiac Arrhythmias and Treatments 2
- Heart Failure Treatment and Management 2
-
- Cardiac Imaging and Diagnostics 13
- Advanced MRI Techniques and Applications 4
-
- Cancer Treatment and Pharmacology 4
- Co-authors
- Thomas H. MarwickFaraz PathanKazuaki NegishiNicholas D’EliaPaaladinesh ThavendiranathanEmily SomersetEitan AmirBernd J. Wintersperger
- Journals
- JACC. Cardiovascular imaging (3 papers)Circulation (2 papers)Journal of the American Society of Echocardiography (2 papers)
- Partner nations
- AustraliaCanadaUnited States
In The Last Decade
Mark Nolan
26 papers receiving 795 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Cardiology and Cardiovascular Medicine 701
- Radiology, Nuclear Medicine and Imaging 388
- Biophysics 17
- Complementary and alternative medicine 20
- Oncology 65
Countries citing papers authored by Mark Nolan
This map shows the geographic impact of Mark Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Nolan more than expected).
Fields of papers citing papers by Mark Nolan
This network shows the impact of papers produced by Mark Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Nolan. The network helps show where Mark Nolan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Nolan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 8 | |
| 6 | 2020 | 55 | |
| 7 | 2020 | 12 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 29 | |
| 10 | 2019 | 34 | |
| 11 | 2019 | 40 | |
| 12 | 2018 | 10 | |
| 13 | 2018 | 2 | |
| 14 | 2017 | 40 | |
| 15 | Abstract 16276: Cost-Effectiveness Analysis of Dexrazoxane in Preventing Long-Term Cardiac Dysfunction in Paediatric Patients With Haematological Malignancies | 2016 | 1 |
| 16 | 2016 | 27 | |
| 17 | 2016 | 7 | |
| 18 | Normal Ranges of Left Atrial Strain by Speckle-Tracking Echocardiography: A Systematic Review and Meta-Analysisbreakdown → | 2016 | 365 |
| 19 | 1999 | 22 | |
| 20 | 1995 | 10 |
About Mark Nolan
Mark Nolan is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Developmental Neuroscience, having authored 28 papers that have together received 813 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (14 papers), Cardiac Imaging and Diagnostics (13 papers), Cardiovascular Function and Risk Factors (9 papers), Cancer Treatment and Pharmacology (4 papers), Advanced MRI Techniques and Applications (4 papers), Cardiac Valve Diseases and Treatments (2 papers), Cardiac Arrhythmias and Treatments (2 papers) and Heart Failure Treatment and Management (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (701 citations), Radiology, Nuclear Medicine and Imaging (388 citations) and Biophysics (17 citations). Mark Nolan has collaborated with scholars based in Australia, Canada and United States. Frequent co-authors include Thomas H. Marwick, Faraz Pathan, Kazuaki Negishi, Nicholas D’Elia, Paaladinesh Thavendiranathan, Emily Somerset, Eitan Amir, Bernd J. Wintersperger, Hong Yang and Maryam Esmaeilzadeh. Their work appears in journals such as JACC. Cardiovascular imaging, Circulation, Journal of the American Society of Echocardiography, International Journal of Cardiology and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.